Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

about

Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention

P2860

Q36117948-5DBC0032-E748-4B4A-9EA9-8F603BBD05CA

P2860

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

Item

http://www.wikidata.org/entity/Q38270917

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

@en

type

Item

label

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

@en

prefLabel

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

@en

P1476

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

@en

P2093

Shintaro Hirata

http://www.w3.org/2001/XMLSchema#string

Yoshiya Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study

Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis.

What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.

Proposal for a new nomenclature of disease-modifying antirheumatic drugs.

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.

P304

115-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2015.984689

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25420554

http://www.w3.org/2001/XMLSchema#string

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

about

P2860

P2860

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698